The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition
Status:
Completed
Trial end date:
2019-01-24
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to evaluate the pharmacokinetics and
safety/tolerability after oral administration of CKD-387 and D484 under fed condition in
healthy adults.